Chinese research team achieves new breakthrough in the field of autoimmune hepatitis treatment

A Chinese research team recently made important progress in the field of autoimmune hepatitis treatment. The research team, jointly led by Qilu Hospital of Shandong University and the School of Pharmacy of Shandong University, proposed a new method based on in vivo cell reprogramming, providing a new approach for the treatment of autoimmune diseases. The related research findings have been published in the international academic journal "Cell Stem Cell".